Gotowa bibliografia na temat „Cancer des voies aérodigestives supérieures”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Cancer des voies aérodigestives supérieures”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Cancer des voies aérodigestives supérieures"
Lefebvre, J. L. "Cancers des voies aérodigestives supérieures". Oncologie 9, nr 7-8 (sierpień 2007): 514–16. http://dx.doi.org/10.1007/s10269-007-0708-z.
Pełny tekst źródłaLefebre, J. L. "Cancers des voies aérodigestives supérieures". Oncologie 10, nr 7-8 (sierpień 2008): 460–61. http://dx.doi.org/10.1007/s10269-008-0931-2.
Pełny tekst źródłaLefebvre, J. L. "Cancers des voies aérodigestives supérieures". Oncologie 11, nr 7-8 (lipiec 2009): 370–72. http://dx.doi.org/10.1007/s10269-009-1096-3.
Pełny tekst źródłaLefebvre, J. L. "Cancers des voies aérodigestives supérieures". Oncologie 12, nr 8 (22.07.2010): 442–44. http://dx.doi.org/10.1007/s10269-010-1923-6.
Pełny tekst źródłaLefebvre, J. L. "Cancers des voies aérodigestives supérieures". Oncologie 13, nr 8 (26.07.2011): 473–75. http://dx.doi.org/10.1007/s10269-011-2049-1.
Pełny tekst źródłaValette, G. "Cancers des voies aérodigestives supérieures". Oncologie 15, nr 7-8 (lipiec 2013): 361–65. http://dx.doi.org/10.1007/s10269-013-2312-8.
Pełny tekst źródłaDoh, K., M. K. Farrej, I. Thiam, E. Tagba i G. Woto-Gaye. "Les voies aérodigestives supérieures, un virus, un cancer". Annales de Pathologie 36, nr 4 (sierpień 2016): 301. http://dx.doi.org/10.1016/j.annpat.2016.06.014.
Pełny tekst źródłaLefebvre, J. L., i D. Chevalier. "Épidémiologie des cancers des voies aérodigestives supérieures". EMC - Oto-rhino-laryngologie 7, nr 2 (czerwiec 2012): 1–11. http://dx.doi.org/10.1016/s0246-0351(12)41900-6.
Pełny tekst źródłaVédrine, L., C. Chargari, S. Le Moulec, M. Fayolle, B. Ceccaldi i O. Bauduceau. "Chimiothérapie des cancers des voies aérodigestives supérieures". Cancer/Radiothérapie 12, nr 2 (marzec 2008): 110–19. http://dx.doi.org/10.1016/j.canrad.2007.11.005.
Pełny tekst źródłaLapeyre, M., B. Coche-Dequéant, J. F. Moreira, J. Le Bourhis i D. Peiffert. "Curiethérapie des cancers des voies aérodigestives supérieures". Cancer/Radiothérapie 17, nr 2 (kwiecień 2013): 130–35. http://dx.doi.org/10.1016/j.canrad.2013.01.007.
Pełny tekst źródłaRozprawy doktorskie na temat "Cancer des voies aérodigestives supérieures"
Larrouy, Anne. "Antibioprophylaxie en chirurgie carcinologique des voies aérodigestives supérieures". Bordeaux 2, 1994. http://www.theses.fr/1994BOR2M070.
Pełny tekst źródłaBlons, Hélène. "Altérations génétiques et cancers des voies aérodigestives supérieures, corrélations anatomo-cliniques". Paris 5, 1999. http://www.theses.fr/1999PA05P041.
Pełny tekst źródłaBozec, Alexandre. "Apport préclinique aux thérapeutiques moléculaires ciblées dans les carcinomes épidermoïdes des voies aérodigestives supérieures". Aix-Marseille 2, 2007. http://www.theses.fr/2007AIX20664.
Pełny tekst źródłaLemaire, Frédéric. "Caractérisation de l'expression génique des tumeurs des voies aérodigestives supérieures : perspectives diagnostiques et thérapeutiques". Paris, Institut national d'agronomie de Paris Grignon, 2004. https://pastel.archives-ouvertes.fr/pastel-00000629.
Pełny tekst źródłaLemaire, Frédéric Jean Laurent. "Caractérisation de l'expression génique des tumeurs des voies aérodigestives supérieures: perspectives diagnostiques et thérapeutiques". Phd thesis, INAPG (AgroParisTech), 2004. http://pastel.archives-ouvertes.fr/pastel-00000629.
Pełny tekst źródłaCromer, Anne. "Identification et caractérisation des gènes différentiellement exprimés dans les cancers des voies aérodigestives supérieures". Université Louis Pasteur (Strasbourg) (1971-2008), 2004. http://www.theses.fr/2004STR13149.
Pełny tekst źródłaHead and neck cancer is responsible for 12% of cancer deaths in men in France. Despite thérapeutical improvement, 5-year survival rates have remained largely unchanged in the last few decades and patients frequently present with locoregional recurrence and metastatic disease (30-50%). The work presented here aimed at identifying genes differentially expressed in HNSCC tumorigenesis, as well as in metastasis progression. Two complementary transcriptome screens were performed using Differential Display and Affymetrix microarrays. Around 3 000 genes were identified that are differentially expressed between hypopharyngeal carcinoma and normal uvula. In addition, we identified 164 genes with distinct expression levels in tumours with different metastatic outcomes. The involvement of some of these genes in cancer have already been decribed (eg. MMPs, CXCR4), whereas others are unknown in public databases. Furthermore, we functional characterized two of these 'unkown' genes: 0656D/LL5b, which encodes a protein binding phosphoinositides (3,4,5) triphosphates, and h1655E, an homolog of NudC, a protein involved in nuclear migration. The sequences we isolated are an exhaustive list of tumorigenesis and metastatic invasion markers in HNSCC. These are potential diagnostic or prognostic markers, and potential therapeutic targets
Thomas, Fabienne. "Mécanismes d'action et de résistance de l'erlotinib dans les cancers des voies aérodigestives supérieures". Toulouse 3, 2007. http://thesesups.ups-tlse.fr/746/.
Pełny tekst źródłaOur work aims to study the action of an EGFR inhibitor (erlotinib) in patients with HNSCC; and to identify predictive markers of response in order to select patients that can benefit of the treatment. Immunochemistry analyses were performed on tumor tissues and show that basal p21waf expression (CDK-cyclins inhibitor) was positively associated with tumor response. EGFR mutations and Kras mutations were not detected in HNSCC patients of our study. . The EGFR gene copy number, that has been identified as a factor linked with tyrosine kinase inhibitors sensitivity in lung cancer, did not correlate with clinical response. We also studied erlotinib pharmacokinetics and try to establish pharmacokinetics/pharmacodynamics relationships (PK /PD relationships). Pharmacokinetic analysis show that the smoking status, the hepatic function and age were relevant covariates to predict erlotinib elimination. Moreover, there is a relationship between drug exposure and toxicity but not between exposure and response. The last part of this work consisted in analysing genomic expression of the tumors before and after treatment by using microarrays (Affymetrix HG U133A GeneChip(r)) to identify genes differentially expressed in responders versus non responders and to characterize erlotinib effect on genes expression
Combes, Jean-Damien. "Epidémiologie des infections à papillomavirus humains et cancers des voies aérodigestives supérieures : enjeux et perspectives de prévention". Thesis, Lyon 1, 2014. http://www.theses.fr/2014LYO10367.
Pełny tekst źródłaAt least one out of six cancers worldwide is caused by infectious agents, of which human papillomaviruses (HPV) are responsible for around 600 000 cancer cases each year. HPV are recognized as a necessary cause of cervical cancer, and the cause of a fraction of cancers of the anus, vulva, vagina, penis, but also the oropharynx. Recent epidemiological data report an alarming increase in the incidence of HPV-induced oropharyngeal cancers in some devel- oped countries, as in North America and North Europe. In cervical cancer, extended knowledge of the natural history of HPV infection and associat- ed lesions has led to the implementation of cervical pap smear screening resulting in a sub- stantial decrease in cervical cancer incidence. Conversely, in HPV-induced head and neck cancers, very few data on the natural history of the disease are available. Today, the mode of transmission of HPV infection and the steps in cancerisation of head and neck tissues are still poorly understood. Although vaccination against HPV should impact the incidence of HPV- induced cancers other than in the cervix, vaccine coverage is insufficient in many countries to generate herd immunity, and to date no other method for prevention of HPV-induced head and neck cancers is available. The main objectives of this work are: (i) to better define the oncogenic potential of the differ- ent HPV types [Articles I, II and III]; (ii) to improve the knowledge of the role of HPV in can- cers of the head and neck [Articles IV and V]; and (iii) to understand the natural history of HPV infection and associated lesions in the oropharynx [Projects I and II]
Carton, Matthieu. "Facteurs de risque professionnels des cancers des voies aérodigestives supérieures chez les femmes : analyse des données de l’étude Icare". Thesis, Université Paris-Saclay (ComUE), 2017. http://www.theses.fr/2017SACLV002/document.
Pełny tekst źródłaBackground : Few occupational studies have addressed head and neck cancer, and these studies have been predominantly conducted in men. Objective : Our objective was to investigate the associations between head and neck cancer and occupational exposures in women Population and methods : ICARE, a French population-based case–control study, included 296 squamous cell carcinomas of the head and neck (HNSCC) in women and 775 female controls. Lifelong occupational history was collected. Job-exposure matrices were used to assess exposure to five chlorinated solvents (carbon tetrachloride; chloroform; methylene chloride; perchloroethylene; trichloroethylene), 5 petroleum solvents (benzene; special petroleum product; gasoline; white-spirits and other light aromatic mixtures; diesel, fuels and kerosene), 5 oxygenated solvents (alcohols; ketones and esters; ethylene glycol; diethyl ether; tetrahydrofuran) and 7 fibers and dusts (asbestos, flour dust, leather dust, refractory ceramic fibers, cement dust, mineral wools and silica) . An analysis by job title was conducted, and then associations with specific occupational exposures were investigated.Odds ratio (ORs) and 95% confidence intervals (CI), adjusted for smoking, alcohol drinking, age and residence area, were estimated with logistic models. Results : Significantly increased HNSCC risks were found for several jobs and industries. Some of these occupations (food and beverage processors, electrical and electronic equipment assemblers, welders and flame cutters) may entail exposure to agents such as solvents, metals, welding fumes and various dusts. Analyses for specific occupational exposures showed a significantly elevated risk of HNSCC associated with exposure to trichloroethylene and perchloroethylene. There is no clear evidence that petroleum or oxygenated solvents, some of them commonly used by women, are risk factors for HNSCC. Exposure to flour dust increased significantly HNSCC risk. Probable exposure to asbestos was associated with a moderate, non-significant elevation in risk. Analyses by cancer site (oral cavity, pharynx, larynx) were hampered by small numbers and did to reveal any specific association.Conclusion : These findings suggest that occupational exposure to perchloroethylene, trichloroethylene and flour dust may increase the risk of HNSCC in women
Jehl, Aude. "Cavéoline-1 prédictive de la métastase et de la rechute locorégionale des cancers des voies aérodigestives supérieures". Thesis, Strasbourg, 2022. http://www.theses.fr/2022STRAJ070.
Pełny tekst źródłaThis translational research project on head and neck cancers has identified caveolin-1 (Cav1) as a prognostic biomarker for the evolution of a primary tumor of these cancers. Indeed, an overexpression of this protein favors a locoregional relapse whereas a deficiency of Cav1 engages the tumor towards a metastatic process. Moreover, we have highlighted the involvement of the Cav1 / EREG / YAP axis in the resistance to treatment (cetuximab and radiotherapy). Finally, we identified epiregulin (EREG) as the key protein in cetuximab resistance. Thus, a deficiency of EREG sensitizes cells to cetuximab by activation of ferroptosis and the association of this target therapy with the RSL3 molecule or metformin drastically restricts cell survival by accentuating this programmed cell death. These last results could be confirmed thanks to a complex 3D model recapitulating the intra- and inter-tumoral heterogeneity, namely the tumoroid model established from surgical parts of patients with head and neck cancer
Książki na temat "Cancer des voies aérodigestives supérieures"
1907-1998, Leroux-Robert Jean, i Laccourreye Henri, red. La Chimiothérapie dans les cancers des voies aéro-digestives supérieures. Paris: Masson, 1987.
Znajdź pełny tekst źródłaCzęści książek na temat "Cancer des voies aérodigestives supérieures"
Desmaris, R., i C. Chenailler. "Cancer des voies aérodigestives et supérieures". W Pharmacie Clinique Pratique en Oncologie, 178–89. Elsevier, 2020. http://dx.doi.org/10.1016/b978-2-294-76375-5.00019-1.
Pełny tekst źródłaRobert, Jacques. "Cancers des voies aérodigestives supérieures". W Ciblage Thérapeutique en Oncologie, 193–94. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77967-1.00026-7.
Pełny tekst źródłaBlondel, Monique, i Thérèse Psiuk. "Prise en charge des patients porteurs d'une sonde d'alimentation entérale pour un cancer des voies aérodigestives supérieures". W Plans de soins types, chemins cliniques et guides de séjour, 213–48. Elsevier, 2010. http://dx.doi.org/10.1016/b978-2-294-71093-3.50014-8.
Pełny tekst źródłaBabin, Emmanuel, i Guillaume Grandazzi. "12. Un système paradoxant ? Soignants et prise en charge des patients en cancérologie des voies aéro-digestives supérieures". W Le cancer : un regard sociologique, 184–99. La Découverte, 2018. http://dx.doi.org/10.3917/dec.norb.2018.01.0184.
Pełny tekst źródłaStreszczenia konferencji na temat "Cancer des voies aérodigestives supérieures"
Roger, Vincent, Jérôme Farinas, Virginie Woisard i Julien Pinquier. "Création d’une mesure entropique de la parole pour évaluer l’intelligibilité de patients atteints de cancers des voies aérodigestives supérieures". W XXXIVe Journées d'Études sur la Parole -- JEP 2022. ISCA: ISCA, 2022. http://dx.doi.org/10.21437/jep.2022-13.
Pełny tekst źródłaHascoët, E., G. Valette, G. Le Toux i S. Boisramé. "Critères d'éligibilité à la réhabilitation implantaire de patients ayant été traités pour un cancer des voies aéro-digestives supérieures : revue de la littérature". W 63ème Congrès de la SFCO, redaktorzy S. Boisramé, S. Cousty, J. C. Deschaumes, V. Descroix, L. Devoize, P. Lesclous, C. Mauprivez i T. Fortin. Les Ulis, France: EDP Sciences, 2015. http://dx.doi.org/10.1051/sfco/20156302009.
Pełny tekst źródłaAnxionnat, C., MA Fauroux, C. Favre de Thierrens, P. Boisselier i JH Torres. "Etude prospective de la prise en charge bucco-dentaire de 51 patients atteints d’un cancer des voies aériennes digestives supérieures avant radiothérapie maxillo-faciale". W 62ème Congrès de la SFCO. Les Ulis, France: EDP Sciences, 2014. http://dx.doi.org/10.1051/sfco/20146202007.
Pełny tekst źródła